Utah Medical Products, Inc.
UTMD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $215 | $306 | $366 | $365 |
| - Cash | $83 | $93 | $75 | $61 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $133 | $214 | $291 | $304 |
| Revenue | $41 | $50 | $52 | $49 |
| % Growth | -18.6% | -3.9% | 6.6% | – |
| Gross Profit | $24 | $30 | $32 | $31 |
| % Margin | 59% | 59.8% | 61.6% | 63% |
| EBITDA | $16 | $25 | $27 | $26 |
| % Margin | 40.2% | 49.3% | 51.4% | 53.3% |
| Net Income | $14 | $17 | $16 | $15 |
| % Margin | 33.9% | 33.1% | 31.5% | 30.1% |
| EPS Diluted | 3.96 | 4.57 | 4.52 | 4.04 |
| % Growth | -13.3% | 1.1% | 11.9% | – |
| Operating Cash Flow | $15 | $22 | $21 | $21 |
| Capital Expenditures | -$0 | -$1 | -$1 | -$1 |
| Free Cash Flow | $15 | $22 | $20 | $21 |